Driada Medical Mentolad 50mg/ml
Driada Medical Mentolad 50mg/ml is a specialized injectable formulation containing Methyltestosterone, a potent 17-alpha-alkylated oral anabolic-androgenic steroid (AAS) adapted for injectable use. While historically known as an oral tablet, this liquid suspension offers an alternative delivery method for researchers investigating the effects of this classic compound. Methyltestosterone is a derivative of testosterone with a methyl group attached at the 17th carbon position, preventing its breakdown by the liver and allowing it to remain active in the bloodstream. This compound is renowned for its ability to rapidly increase strength, aggression, and libido. However, due to its potent nature and specific metabolic pathway, Mentolad is strictly reserved for advanced research protocols where rapid onset and short-duration effects are required. It does not convert to estrogen via standard aromatase pathways in the same manner as testosterone, but it can still cause estrogenic side effects through other mechanisms.
Key Features
- Contains 50mg/ml of Methyltestosterone in a specialized suspension
- 17–alpha-alkylated structure ensures high bioavailability and resistance to hepatic degradation
- Rapid onset of action, providing immediate effects on strength and aggression
- Historically used for treating hypogonadism and delayed puberty (research context only)
- Does not require conversion to another compound to be active; it is active as administered
- Short half-life necessitates frequent administration for stable levels
- Manufactured by Driada Medical under strict pharmaceutical quality and sterility standards
- Ideal for short-term research protocols requiring potent androgenic stimulation
Where to Buy
Driada Medical Mentolad 50mg/ml is available through specialized pharmaceutical distributors, verified research chemical suppliers, and licensed laboratories. Due to the rarity of injectable Methyltestosterone and the prevalence of counterfeit oral steroids, verifying the source is critical. Buyers must authenticate products using holographic security seals, batch verification codes, and the official Driada Medical portal. Purchasing from unregulated sources risks exposure to under-dosed solutions, contaminated suspensions, or incorrect substances. Always request a Certificate of Analysis (COA) to confirm purity, sterility, and correct dosage before any research application.
Product Specifications
- Active Ingredient: Methyltestosterone
- Concentration: 50mg/ml
- Form: Injectable suspension (micro-crystal)
- Package Size: 10ml vial (varies by distributor)
- Chemical Structure: C20H30O2 (17-alpha-methyltestosterone)
- Half-life: Approximately 6-8 hours
- Detection Time: Up to 6 weeks in urine screenings (strictly prohibited by WADA)
- Storage: Store at room temperature (20-25°C), protect from light and moisture. Do not freeze.
Mechanism of Action
Mentolad functions by binding directly to androgen receptors, triggering increased protein synthesis and nitrogen retention. As a 17-alpha-alkylated compound, it survives first-pass metabolism in the liver, allowing it to exert powerful systemic effects quickly. Unlike testosterone, which requires conversion to dihydrotestosterone (DHT) for certain androgenic effects, Methyltestosterone is already structurally modified to be highly androgenic. It can aromatize to a limited extent, leading to potential estrogenic side effects, although its primary mechanism is direct androgen receptor activation. The compound also suppresses sex hormone-binding globulin (SHBG), increasing the amount of free testosterone in the system, which amplifies the effects of other anabolic agents if used in combination.
Metabolic Impact
The metabolic effects of Methyltestosterone are characterized by rapid increases in strength, aggression, and red blood cell production. It can stimulate appetite significantly, which may be useful in specific research contexts involving wasting conditions. However, the 17-alpha alkylation makes it highly hepatotoxic (liver toxic), posing severe risks even with short-term use. It negatively impacts lipid profiles by drastically lowering HDL (good cholesterol) and raising LDL (bad cholesterol), creating significant cardiovascular strain. The compound does not promote lean mass gains as effectively as modern esters and is primarily associated with strength and androgenic effects rather than quality muscle tissue accumulation.
Conclusion
Driada Medical Mentolad 50mg/ml is a niche, high-potency compound reserved for specific research applications requiring rapid androgenic stimulation. Its unique profile as an 17-alpha-alkylated injectable makes it distinct, but its severe toxicity profile limits its utility. It is not suitable for long-term use or for individuals concerned with liver health or cardiovascular safety. This product is strictly for advanced, short-term research protocols under professional supervision.
Safety Warning
Mentolad carries severe health risks including acute liver toxicity, liver failure, cardiovascular strain, and severe lipid profile degradation. Side effects include extreme aggression (“roid rage”), acne, hair loss, and virilization in women. It suppresses natural testosterone production completely, necessitating Post Cycle Therapy (PCT). This product is not for recreational use. Consult a licensed physician before administration. Do not use if you have pre-existing liver conditions, heart disease, or are under 21 years old. Regular blood work monitoring (especially liver enzymes) is mandatory. This information is provided for educational purposes only. Actually using this product without medical supervision is illegal in many jurisdictions and could land you in serious legal trouble.




Reviews
There are no reviews yet.